Even when blood alcohol levels are half the legal driving limit, people tend to miss objects that appear suddenly in their field of vision, reports a study done by researchers at the University of Washington.

The phenomenon, which is commonly called intentional blindness, happens in people who are sober as well. Dr. Seema L.Clifasefi observes that alcohol has been known to impair motor skills, reaction time and visual attention. However, until now no one has looked into the effects of alcohol on intentional blindness

A new study published in the June issue of the American Journal of Psychiatry finds that children who were exposed to psychotropic medications in utero do not appear to be at increased risk for internalizing behaviors such as depression, anxiety, and withdrawal.

However, impaired maternal mood, by contrast, did increase the risk of internalizing behaviors

The Food and Drug Administration approves Lucentis for the treatment of patients with neovascular (wet) age-related macular degeneration. Lucentis is the first treatment which can maintain the vision of more than 90 percent of patients with this type of AMD.

The FDA says Lucentis is a new molecular entity, meaning it contains an active substance that has never before been approved for marketing in any form in the U.S. Lucentis will be the first FDA-approved product to provide prescription information in the new format for prescription drug package inserts. These are designed to provide professionals and consumers clear and concise prescription information

A study by researchers at University of Utah has shown that the people who talk on their cell phones while driving are as impaired as drunk drivers. The results of the studied are applied even to those who, though, kept their hands free by using "hand-free" devices.

In their study, researchers made the 40 volunteers use a driving simulator four times- once with no distractions, once using a handheld cell phone, once using a hands-free cell phone and once while intoxicated to a 0.08 percent blood-alcohol level after drinking vodka and orange juice. (the average legal level of impairment in the U.S

The Food and Drug Administration approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.

Parkinson's is a disorder of the central nervous system that causes chronic loss or impairment of intellectual capacity